POC Market Opportunity Ohmx focuses on point-of-care diagnostics that quantify DNA, proteins, and small molecules from low-volume samples, presenting a compelling opportunity to supply healthcare providers with a single, portable analyzer for screening, diagnosing, and monitoring both chronic and acute conditions at the point of care.

Cost-Efficient Platform The emphasis on a low-cost, comprehensive platform positions Ohmx to appeal to budget-conscious clinics and outpatient facilities seeking to reduce per-test costs while expanding testing capabilities at the point of care.

Targeted Expansion With a portable blood analyzer capable of rapid screening and preventive medicine applications, there is potential to partner with hospitals, urgent care centers, and primary care networks aiming to improve preventive care and early disease management.

Strategic Partnerships Ohmx’s all-in-one quantitative capability across DNA, proteins, and small molecules may attract collaborations with medical device manufacturers, diagnostics distributors, and healthcare IT platforms to integrate data workflows and expand market reach.

Funding and Growth Readiness Current revenue signals a small-to-mid-scale operation; combined with existing funding, there is an opportunity to pursue grant programs, strategic investors, or tiered commercialization partnerships to accelerate market entry and scale adoption.